Source: PRLOG

Press Release: Global Allied Pharmaceuticals : Chemical Linker Technology as a composition of Antibody Drug Conjugates

This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Nepton Sheik Khoni

CEO Approval Rating

70/100

Read more